Optimizing Machine learning methods to improve predictive models of Alzheimer’s disease

Manuscript Number: 

19-0262R1

Author(s): 
Ali Ezzati, Christian Habeck, Charles B. Hall, Danielle Harvey, Richard B. Lipton, Andrea R. Zammit

Disclosures

Ali Ezzati

  • Consulting Fees:
    Dr. Ezzati serves as an advisory board member of: Eisai

Christian Habeck

  • Nothing to Disclose

Charles B. Hall

  • Nothing to Disclose

Danielle Harvey

  • Consulting Fees:
    Dr. Harvey serves on the Statistical Advisory Board for PLoS One.

Richard B. Lipton

  • Consulting Fees:
    Dr. Lipton serves as consultant, advisory board member, or has received honoraria from: American Academy of Neurology, Alder, Allergan, American Headache Society, Amgen, Autonomic Technologies, Avanir, Biohaven, Biovision, Boston Scientific, Dr. Reddy’s, Electrocore, Eli Lilly, eNeura Therapeutics, GlaxoSmithKline, Merck, Pernix, Pfizer, Supernus, Teva, Trigemina, Vector, Vedanta. He receives royalties from Wolff’s Headache 7th and 8th Edition, Oxford Press University, 2009, Wiley and Informa.
    Equity:
    Dr. Lipton holds stock options in eNeura Therapeutics and Biohaven Holdings.

Andrea R. Zammit

  • Nothing to Disclose